And Peter Peduzzi.

Albert C. Lo, M.D erectile dysfunction treatment ., Ph.D., Peter D. Guarino, M.P.H., Ph.D., Lorie G. Richards, Ph.D., Jodie K. Haselkorn, M.D., M.P.H., George F. Wittenberg, M.D., Ph.D., Daniel G. Federman, M.D., Robert J. Ringer, Pharm.D., Todd H. Wagner, Ph.D., Hermano I. Krebs, Ph.D., Bruce T. Volpe, M.D., Christopher T. Bever, Jr., M.D., M.B.A., M Dawn. Bravata, M.D., Pamela W. Duncan, Ph.D., Barbara H. Corn, Ph.D., Alysia D. Maffucci, J.D., Stephen E. Nadeau, M.D., Susan S. Conroy, D.Sc., P.T., Janet M. Powell, Ph.D., Grant D. Huang, Ph.D., and Peter Peduzzi, Ph.D.: Robot-Assisted Therapy for Long-Term Upper-Limb Impairment after Stroke..

Prices of overall adverse events, serious adverse events, and noncardiovascular factors behind death are listed in Desk S2 in the Supplementary Appendix. Discussion Patients who have had a myocardial infarction remain in heightened risk for ischemic events over the long term.3-5 In the PEGASUS-TIMI 54 trial, the addition of the P2Y12 receptor antagonist ticagrelor to low-dose aspirin in patients 1 to three years after a myocardial infarction significantly reduced the risk of cardiovascular loss of life, myocardial infarction, or stroke.